All
I have been sued under the ADA
April 30th 2015The Americans with Disabilities Act of 1990 (ADA) provides a general legal framework for access of individuals with disabilities to public places and also for accommodating employees with disabilities in the workplace. Although the ADA contains very specific guidance for physical accommodations, such as wheelchair access, it provides little guidance relevant to workers with conditions such as diabetes.
The latest in scar remodeling: High-powered CO2 lasers
April 26th 2015High-powered CO2 lasers are making news in scar remodeling. The devices allow dermatologists to go deep into the scar, increase scar mobility and even encourage normal skin formation in the treated area, according to this expert presenter.
Using lasers to correct laser and IPL-induced side effects
April 26th 2015It might seem counter-intuitive - even scary - but patients and their dermatologists should consider laser therapy as a first-line approach for treating laser and intense pulsed light (IPL)-induced scarring and dyspigmentation.
Novel uses for lasers, energy-based devices
April 24th 2015Novel uses for tried-and-true laser and energy-based technologies are improving the treatment of darker skin types and outcomes for a variety of skin conditions, according to a presentation by New York City-based dermatologist Roy G. Geronemus, M.D., and colleagues at yesterday’s American Society for Laser Medicine & Surgery 2015 annual conference in Kissimmee, Fla.
Treatment pearls for pediatric vascular lesions
April 24th 2015Technologies and techniques dermatologists use to treat vascular lesions in children are improving, resulting in better outcomes for young patients, according to a presentation by New York City-based dermatologist Roy G. Geronemus, M.D., and colleagues at yesterday’s American Society for Laser Medicine & Surgery 2015 annual conference in Kissimmee, Fla.
Reducing wrinkles over larger area with diluted abobotulinum toxin A (Video)
April 9th 2015A study comparing concentrations of abobotulinum toxin A and onabotulinum toxin A for reduction of forehaead wrinkles found that and increased dilution of abobotulinum toxin A results in a greater surface area coverage.
PODCAST: Expert insights in managing vitiligo, part 2 on dyspigmentation
April 1st 2015Two of the most vexing skin conditions that dermatologists manage are melasma and vitiligo. In one condition, too much pigmentation is present because of genetic, hormonal and environmental factors. In the other, there is a lack of melanin in the skin, presumably on an autoimmune basis. In part two of this discussion on dyspigmentation conditions, Seemal Desai, M.D., who is a board-certified dermatologist, clinical assistant professor in the department of dermatology at University of Texas, Southwestern Medical Center in Dallas, and medical director of Innovative Dermatology, discusses treatment options for vitiligo with Dermatology Times editorial advisor, Dr. Norman Levine.